Methotrexate (MTX) works in early PsA. Confirms what we see in clinical practice
◦ Mean disease duration 0.6y
◦ bDMARD naive
◦ MTX monotherapy
➢ ACR20 50.7%
➢ ACR50 30.6%
➢ MDA 22.9%
Good to know, our trusted friend MTX works
Jose Scher #ReviewCourse @RheumNow #ACR22
◦ Mean disease duration 0.6y
◦ bDMARD naive
◦ MTX monotherapy
➢ ACR20 50.7%
➢ ACR50 30.6%
➢ MDA 22.9%
Good to know, our trusted friend MTX works
Jose Scher #ReviewCourse @RheumNow #ACR22
